HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 10, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
, a leading developer of adult stem cell technologies for neurodegenerative diseases, will announce financial results for the three and six months ended June 30, 2017 and provide important corporate updates on Wednesday, August 16th.
